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Abstract
 
The macrophage is well established as a target of HIV and simian immunodeficiency virus
(SIV) infection and a major contributor to the neuropathogenesis of AIDS. However, the
identification of distinct subpopulations of monocyte/macrophages that carry virus to the brain
and that sustain infection within the central nervous system (CNS) has not been examined. We
demonstrate that the perivascular macrophage and not the parenchymal microglia is the pri-
mary cell productively infected by SIV. We further demonstrate that although productive viral
infection of the CNS occurs early, thereafter it is not easily detectable until terminal AIDS.
The biology of perivascular macrophages, including their rate of turnover and replacement by
peripheral blood monocytes, may explain the timing of neuroinvasion, disappearance, and re-
appearance of virus in the CNS, and questions the ability of the brain to function as a reservoir
for productive infection by HIV/SIV.
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Introduction
 
Historically, the central nervous system (CNS)
 
1
 
 has been
considered immune privileged, being devoid of cells of the
peripheral immune system (1). As an extension of this no-
tion, it has been postulated, but not demonstrated, that the
CNS is a reservoir or sanctuary for HIV (2, 3). Implicit
with the CNS functioning as a viral sanctuary is the as-
sumption that once virus enters it is sequestered from im-
mune surveillance, and viral replication is maintained for
long periods of time, until the development of AIDS and
AIDS dementia complex (ADC [4]). Evidence for this is
underscored by publications that resident brain macropha-
ges, known as parenchymal microglia, are the cell type in
the CNS infected by HIV/simian immunodeficiency virus
(SIV [5, 6]). Numerous in vitro studies with microglia
support this contention (7–14). Parenchymal microglia
represent a stable brain macrophage population with an
extremely low level of turnover (15–17). Thus, if this cell
population were infected, it would be expected that the
CNS might serve as a reservoir or sanctuary for infection.
In addition to parenchymal microglia, the CNS contains
a variety of distinct macrophage populations, including
meningeal, choroid plexus, and perivascular macrophages
(15, 16, 18–22). These brain macrophages are distinguished
by their anatomic location within the CNS, rate of turn-
over, morphology, and immunophenotype (23). In HIV
and SIV encephalitis (HIVE/SIVE), multinucleated giant
cells (MNGCs) are also present and are a hallmark of dis-
ease. Publications describing HIV or SIV infection of the
CNS refer to infection of microglia or macrophages with-
out attempting to further define the cell type(s). In most
studies, it appears that the data refer to parenchymal micro-
glia or perivascular macrophages as the main cell infected
(5, 12, 13, 24–32). Meningeal and choroid plexus mac-
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Abbreviations used in this paper: 
 
ADC, AIDS dementia complex; CNS,
central nervous system; DIC, differential interference contrast; DIG,
digoxigenin; GFAP, glial fibrillary acidic protein; Glut-1, glucose trans-
porter 1; HIVE/SIVE, HIV/SIV encephalitis; MNGC; multinucleated
giant cell; p.i., postinfection; RCA-1, 
 
Ricinus comminis
 
 agglutinin 1; SIV,
simian immunodeficiency virus. 
906
 
Perivascular Brain Macrophages in SIV Infection
 
rophages are rarely considered as major targets of HIV/SIV,
although both populations are infected (33, 34). The biol-
ogy and kinetics of turnover of perivascular macrophages
versus parenchymal microglia are very different and may
have a major influence on whether the brain functions as a
retroviral reservoir. In contrast to parenchymal microglia
which turn over very slowly (15–17, 35), 
 
z
 
30% of perivas-
cular macrophages turn over every 2–3 mo (15, 16).
Both perivascular macrophages and parenchymal mi-
croglia are intimately juxtaposed with CNS endothelial
cells (20). Perivascular macrophages wrap around CNS
vessels. Parenchymal microglia maintain a reticular net-
work throughout the CNS and also comprise part of the
blood–brain barrier with 5–13% of foot processes be-
longing to parenchymal microglia (15, 17). Thus, both
perivascular macrophages and parenchymal microglia are
positioned to encounter agents entering the CNS via the
vasculature and are likely targets of HIV/SIV infection.
Additionally, perivascular macrophages and parenchymal
microglia are bone marrow derived and have the ability to
express CD4 and chemokine receptors, including CC
chemokine receptor (CCR)3, CCR5, and CXC chemo-
kine receptor (CXCR)4, which are coreceptors for HIV
and SIV (14, 36, 37). Although both populations of brain
macrophages could be HIV/SIV infected in vivo, this has
not been critically studied. Given the markedly different
biology of these cell populations, it would be expected
that they function differently with regard to their ability to
support viral replication and in their contribution to viral
pathogenesis. To address the role of different populations
of brain macrophages in neuroinvasion and the develop-
ment of encephalitis, we have used the SIV macaque
model of AIDS.
We have differentiated between perivascular macro-
phages, parenchymal microglia, and MNGCs (when present)
based on the expression of myeloid markers (38–42). We
hypothesized that an immunophenotypically distinct sub-
population of brain macrophage is the major cell infected
in the CNS. Herein we report that perivascular macro-
phages and not resident parenchymal microglia are the major
cell population productively infected in the CNS during
peak viremia (2 wk postinfection [p.i.]) and in animals with
terminal AIDS and SIVE. Furthermore, using CNS tissues
from serial sacrifice studies, we demonstrate that viral DNA
once detected in the CNS of infected animals is present
throughout the course of infection. In contrast, viral RNA
and protein are found early, within 7 to 14 d p.i., but then
become difficult to detect until terminal AIDS and the de-
velopment of SIVE (28–30, 43–45). Our finding that
perivascular macrophages are the major cell type produc-
tively infected at peak viremia and in animals with SIVE
may in part account for the observed timing of neuroinva-
sion, disappearance, and reappearance of viral RNA and
protein in the CNS. The biology of perivascular macro-
phages, including their fairly rapid turnover and replace-
ment by peripheral blood monocyte/macrophages, has im-
portant implications for understanding viral neuroinvasion
and clearance. These data question whether the CNS func-
 
tions as a reservoir for productive infection in the face of
long-term, successful, highly active antiretroviral therapy
(HAART).
 
Materials and Methods
 
Animals and Viral Infection.
 
A total of 34 animals were used in
two related studies. In the first study, 14 juvenile rhesus macaques
(
 
Macaca mulatta
 
) were used to identify the cell types in the CNS
infected at peak viremia and in animals with terminal AIDS and
SIVE. These animals were infected with SIVmac251 (20 ng of
SIV p27) by intravenous injection and killed at peak viremia or
terminal AIDS. The 14 animals examined included 2 normal un-
infected controls, 5 SIV-infected animals at peak viremia and neu-
roinvasion (2 wk p.i.), and 7 SIV-infected macaques with terminal
AIDS. Of the animals with terminal AIDS, five had SIVE. We de-
fine SIVE as perivascular aggregates of mononuclear cells and
MNGCs containing virus (29–31, 46). Animals with scattered
perivascular cuffs (typically found early in infection) have enceph-
alitis but are not characterized as SIVE because they lack MNGCs.
CNS
 
 
 
tissues from an additional 20 juvenile macaques that had
been infected with SIVmac239 (20 ng of SIV p27 intravenously;
 
n 
 
5
 
 10) or SIVmac251 (20 ng of SIV p27 intravenously; 
 
n 
 
5
 
 10)
and killed at 3, 7, 14, 21, and 50 d p.i. (two animals/time point
for each virus) were used to assess SIV DNA, RNA, and protein
(p28 and gp120) during disease progression. In addition to tissues
from these 20 animals, CNS tissue from the 5 animals with SIVE
described above were also used for this analysis. All animals were
housed at Harvard University’s New England Regional Primate
Research Center in accordance with standards of the American
Association for Accreditation of Laboratory Animal Care.
 
Tissue Collection and Processing.
 
Animals were anesthetized
with Ketamine HCl, killed by intravenous pentobarbital over-
dose, and exsanguinated. CNS tissues were collected in 10% neu-
tral buffered formalin, embedded in paraffin, sectioned at 6 
 
m
 
m,
and stained with hematoxylin and eosin by routine histologic
techniques. Adjacent tissues were snap-frozen in optimum cut-
ting temperature compound (OCT; Miles Inc.), by immersion in
2-methylbutane in dry ice.
 
Immunophenotype of Brain Macrophage Subpopulations.
 
Rou-
tine, single-label immunohistochemistry was performed on frozen
sections from animals killed at peak viremia (2 wk p.i.) and ani-
mals with terminal AIDS and SIVE. Markers used included CD4
(Nu Th/I; from M.M. Yokoyama and Y. Matuso, Nicheri Res
Institute, Tokyo, Japan), CD11b (Bear1; Immunotech), CD14
(AML-2-23; Medarex), CD16 (2H7; Novocastra), CD40 (FUN-1;
Ancell), CD45/CD45RB (PD7/26; Dako), CD68 (EBM-11;
Dako), CD69 (FN50; Dako), and HLA-DR (CR3/43; Dako).
 
Immunophenotype of Infected Cells.
 
To examine the immu-
nophenotype of infected cells we performed either: (a) in situ hy-
bridization for SIV on frozen sections followed by immunohis-
tochemistry for macrophage-specific markers on adjacent serial
sections; or (b) double-label immunohistochemistry. For in situ
hybridization followed by immunohistochemistry on serial sec-
tions, frozen sections were cut at 6 
 
m
 
M with the first section sub-
jected to in situ hybridization followed by immunohistochemis-
try on the adjacent serial section for CD14 or CD11b. The probe
for in situ hybridization consists of the entire SIVmac239 ge-
nome. The probe was labeled with digoxigenin (DIG)-11-dUTP
by random priming (Boehringer) and used as described previ-
ously under conditions to detect both viral RNA and DNA (47).
Double-label immunohistochemistry on the same tissue sec- 
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tions was used to localize virus using Senv71.1 (SmithKline Be-
cham) that recognizes SIVgp120 followed by antibodies against
CD14 as described previously (48, 49).
 
Confocal Microscopy.
 
Immunofluorescence confocal micros-
copy was used to identify subpopulations of brain macrophages,
determine their anatomic location relative to CNS endothelium,
and define which populations were infected by SIV. CNS tissues
embedded in optimum cutting temperature compound were se-
lected from animals that were infected and killed 2 wk p.i., with
SIV but no CNS disease, and animals with SIVE. Sections 20-
 
m
 
m
thick were fixed with 2% paraformaldehyde for 15 min on ice.
Thereafter, sections were washed with PBS/FSG (PBS diluted
to 1
 
3
 
 with ddH
 
2
 
0, 0.2% fish skin gelatin) and permeabilized
by treatment with PBS/FSG and 0.1% Triton X-100 (Sigma-
Aldrich) for 1 h. Sections were then washed with PBS/FSG at room
temperature and blocked with 10% normal goat serum diluted in
PBS/FSG. Primary antibodies were diluted in 10% normal goat
serum incubated overnight or for 1 h at 4
 
8
 
C. CD11b-FITC
(Bear1; Immunotech), CD14-allophycocyanin (APC; M5E2; BD
PharMingen) and human glial fibrillary acidic protein (GFAP)-
Cy3 (G-A-5; Sigma-Aldrich) were used as directly labeled anti-
bodies. Glucose transporter 1 (Glut-1) (rabbit polyclonal; Chemi-
con) and anti-SIV P28 (3F7; American Biotech) were used
followed by anti–rabbit Alexa 568 or anti–mouse 488 (Molecular
Probes). Sections were washed with PBS/FSG before the addi-
tion of the next primary or secondary antibody. Secondary anti-
bodies were also diluted in 10% normal goat serum and incubated
for 30 min. After antibody treatment, sections were rinsed in
PBS/FSG, then placed in ddH
 
2
 
0 for 1 min. To quench endoge-
nous autofluorescence by lipofuscin in CNS macrophages, sec-
tions were treated with a 50 mM CU
 
3
 
SO
 
4
 
 in ammonium acetate
buffer for 45 min (50). The sections were then rinsed in ddH
 
2
 
O
and mounted with aqueous medium (Vectashield; Vector Labora-
tories).
Confocal microscopy was performed using a Leica TCS SP la-
ser scanning microscope equipped with three lasers (Leica). Indi-
 
vidual optical slices represent 0.2 
 
m
 
m, and 32 to 62 optical slices
were collected at 512 
 
3
 
 512 pixel resolution. The fluorescence of
individual fluorochromes was captured separately in sequential
mode, after optimization to reduce bleed-through between chan-
nels (photomultiplier tubes) using Leica software. NIH-image
v1.62 and Adobe Photoshop v4 software were used to assign cor-
rect colors of up to five channels collected including four fluoro-
chromes: FITC or Alexa 488 (green), Cy3 (yellow), Alexa 568
(red), and CY5 (blue), and the differential interference contrast
image (gray scale). Colocalization of antigens is indicated by the
addition of colors as indicated in the figure legends.
 
Determination of Productive Infection of the CNS by SIV.
 
Assess-
ment of SIV DNA, RNA, and protein in the CNS from 25 mon-
keys infected with SIV was done using PCR, in situ hybridiza-
tion with riboprobes, and immunohistochemistry, respectively.
Nested PCR for viral DNA was performed using sequences for
SIVgag. DNA was isolated from tissues using QIAGEN DNA
isolation kit as per the manufacturer’s instructions with an addi-
tional overnight incubation with proteinase K at 55
 
8
 
C. 200 ng of
genomic DNA was amplified using nested primers (10 pmol/50
 
m
 
l reaction) for SIVgag (outer 5
 
9
 
, 5
 
9
 
-CTA CGA CCC AAC
GGC AAG-3
 
9
 
; outer 3
 
9
 
, 5
 
9
 
-TTG CTT CCT CAG TGT GTT
TC-3
 
9
 
; inner 5
 
9
 
, 5
 
9
 
-GAA AGC CTG TTG GAG AAC AAA
GAA GGA-3
 
9
 
; inner 3
 
9
 
, 5
 
9
 
-AGT GTG TTT CAC TTT CTC
TTC TGC GTG-3
 
9
 
) with 2 mmol/liter MgGl
 
2
 
 and denatured at
92
 
8
 
C for 2 min. The amplification profile consisted of 30 s at
92
 
8
 
C, 30 s at 61
 
8
 
C, and 30 s at 72
 
8
 
C for 30 cycles followed by an
extension time of 10 min at 72
 
8
 
C. PCR products were visualized
on an ethidium bromide–impregnated agarose gel.
In situ hybridization for SIV RNA was performed using DIG-
labeled antisense riboprobes obtained from Drs. V. Hirsch and C.
Brown (National Institutes of Health, Rockville, MD; reference
51). Tissues were subjected to microwave pretreatment and hy-
bridized overnight at 45
 
8
 
C with 10 ng of antisense riboprobe.
Hybridized probe was detected with alkaline phosphatase–conju-
gated anti-DIG antibody using standard immunological methods.
Figure 1. CD11b immunoreactivity in the CNS of normal noninfected and SIV-infected macaques. (A) CD11b immunoreactivity on nonactivated
parenchymal microglia with branched and crenulated processes in a normal noninfected animal. These cells makeup a reticular branching network
throughout the white matter in the CNS. (B) CD11b immunoreactivity on parenchymal microglia in the CNS of an animal with SIVE. Microglia main-
tain a reticular network in the CNS but morphologically become more rounded with fewer processes, consistent with cellular activation. 
908
 
Perivascular Brain Macrophages in SIV Infection
Control slides consisted of serial sections hybridized with DIG-
labeled sense probe. Viral protein was detected by immunohis-
tochemistry as described above.
 
Results
 
Perivascular Macrophages Are Immunophenotypically Distinct
from Parenchymal Microglia.
 
Several studies have used my-
eloid markers to distinguish between resident parenchymal
microglia and perivascular macrophages in rodents and hu-
mans by flow cytometry and immunohistochemistry where
CD45 expression can identify perivascular macrophages in
mice, and CD14 and CD45 expression can distinguish be-
tween perivascular macrophages and parenchymal micro-
glia in humans (38, 39, 42). We applied this same approach
to brains of normal noninfected rhesus macaques (
 
n
 
 
 
5
 
 2)
and macaques infected with SIVmac251 and killed at peak
viremia (2 wk p.i.; 
 
n 
 
5
 
 5) or terminal AIDS (
 
n
 
 
 
5
 
 7). Of
the animals with terminal AIDS, five had SIVE and two
did not. Brain tissue from these animals was screened with
a panel of monoclonal antibodies against myeloid antigens
including CD4, CD11b (CR3), CD14, CD45, and CD68.
All brain macrophage populations were positive for CD11b
Figure 2. Immunophenotype of parenchymal microglia and perivascu-
lar macrophages in macaques with SIVE. (A) CD11b immunoreactivity
on brain macrophages. Immunoreactivity is demonstrated on parenchy-
mal microglia evenly spaced throughout the white matter, and on expan-
sive aggregates of perivascular macrophages and MNGCs typical of SIVE.
(B) CD14 immunoreactivity on perivascular macrophages within a SIVE
lesion. CD14 is not detected on parenchymal microglia. (C) CD45 im-
munoreactivity on perivascular macrophages and lymphocytes within an
SIVE lesion. CD45 is not detected on parenchymal microglia. (D) Viral
envelope protein (gp120) in SIVE. The distribution of SIV-gp120 appears
to overlap with the distribution of CD11b1CD141CD451 perivascular
macrophages (A–C). Data presented here are representative of immuno-
histochemical studies performed on two to three CNS regions of n 5 5
animals with SIVE.
 
Table I.
 
Immunophenotypes of Perivascular Macrophages, 
Parenchymal Microglia, and MNGCs
 
Perivascular
macrophage
Parenchymal
microglia MNGC
CD11b CD11b CD11b
CD68 CD68 CD68
CD14
 
2
 
CD14
CD45
 
2
 
CD45
Results presented are representative of immunohistochemical studies of
 
n
 
 
 
5
 
 5 animals with terminal AIDS and SIVE. These results are
consistent with previous work differentiating perivascular macrophages
and parenchymal microglia in rodents and humans (references 38, 39,
41, and 42).
 
and CD68. The CD11b
 
1
 
 parenchymal microglia formed a
reticular network of finely branched processes throughout
the brain. This reticular network was maintained in animals
with SIVE, although the cells were rounded rather than
ramified, indicative of cellular activation associated with
SIV infection (Fig. 1). CD14 and CD45 were not detected
on microglia in the CNS parenchyma. These observations
are consistent with the lack of CD14 and CD45 detected
on parenchymal microglia within inflamed human tissues
(38, 39, 52) and the lack of CD14 on immediately ex vivo
human microglial cells (41, 53). CD14 and CD45 expres-
sion was restricted to scattered cells with a perivascular lo-
cation (perivascular macrophages) in normal brain and on
macrophages within meninges and the choroid plexus.
CD14 and CD45 were readily detected on perivascular
macrophages within the CNS parenchyma of animals 2 wk
p.i., at the time of peak viremia and SIV neuroinvasion
(28–30, 43). The number of CD14
 
1
 
 and CD45
 
1 
 
cells was
greater in animals with SIVE than in animals at 2 wk p.i. re-
sulting from the accumulation and recruitment of perivas-
cular macrophages (31; Fig. 2). Low to nondetectable levels
of CD4 were observed on perivascular macrophages and
microglia in the normal brain (data not shown). 2 wk
p.i., CD4 immunoreactivity was slightly more prevalent,
whereas in animals with SIVE, CD4 was readily detected
on perivascular macrophages and scattered parenchymal
microglia (data not shown). The MNGCs, thought to con-
sist of fused macrophages or microglia, were strongly
CD14
 
1
 
 and CD45
 
1
 
 with variable but low expression of
CD4. These data provide a basis for differentiating in vivo
between perivascular macrophages, MNGCs, and paren-
chymal microglia based on the expression of CD11b,
CD14, and CD45 (Table I). On initial inspection, it ap-
peared that the viral protein (gp120)-positive cells in the
CNS of animals with SIVE had a distribution that over-
lapped with CD11b
 
1
 
, CD14
 
1
 
, and CD45
 
1
 
 perivascular
macrophages (Fig. 2). Thus, further studies were performed
to determine whether the perivascular macrophage was
preferentially infected by SIV in the CNS of macaques. 
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Perivascular Macrophages and Not Parenchymal Microglia Are
Infected by SIV.
 
The immunophenotypic differences be-
tween perivascular macrophages and parenchymal micro-
glia described above were used to examine the cell types
that accumulate and are infected in the CNS of SIV-
infected macaques. This was approached in three ways: (a) in
situ hybridization for SIV followed by immunohistochem-
istry for CD14 on serial sections, (b) double-label immuno-
histochemistry for CD14 and gp120, and (c) multilabel
 
confocal microscopy for viral protein and brain macro-
phage, astrocyte, and endothelial cell markers.
In situ hybridization for viral nucleic acid followed by
CD14 immunohistochemistry on serial sections demon-
strated scattered individual positive cells in perivascular cuffs
of animals at peak viremia (2 wk p.i.; Fig. 3). The immu-
nophenotype of these cells was consistent with perivascular
macrophages. In all sections examined, these SIV RNA-
positive CD14
 
1
 
 cells were also gp120
 
1
 
. These data clearly
demonstrate that CD14
 
1
 
 perivascular macrophages are pro-
ductively infected by SIV within 14 d of infection (Fig. 3).
Double-label immunohistochemistry on animals with
terminal AIDS and SIVE revealed that essentially all of the
gp120
 
1
 
 cells were CD14
 
1
 
 perivascular macrophages. Addi-
tionally, all MNGCs were strongly gp120
 
1
 
 and CD14
 
1
 
,
suggesting that these cells arise from the fusion of perivas-
cular macrophages and not fused parenchymal microglia
(Fig. 4). MNGCs were also CD11b
 
1
 
 and CD68
 
1
 
 but
CD3
 
2
 
, consistent with their lineage as myeloid cells (data
not shown; references 5 and 25). Quantitation of the per-
centage of macrophages that were CD14
 
1
 
/gp120
 
1 
 
and
CD14
 
1
 
/gp120
 
2
 
 in the CNS of animals with SIVE re-
vealed that noninfected perivascular macrophages (CD14
 
1
 
/
gp120
 
2
 
) were the most numerous cell type within SIVE
lesions, followed by infected perivascular macrophages
(CD14
 
1
 
/gp120
 
1
 
; Table II). Less than 1% of the cells were
CD14
 
2
 
/gp120
 
1
 
. These rare virally infected cells that were
not CD14
 
1
 
 perivascular macrophages are likely to be either
CD14
 
2
 
 parenchymal microglia or CD4
 
1
 
 T lymphocytes
(Fig. 4). Our finding that the major cell type in SIVE le-
sions is the noninfected perivascular macrophages is consis-
tent with previous data (31) and observations in humans of
a correlation between numbers of inflammatory macro-
phages, as opposed to viral load, and the development of
ADC (54). These data are also consistent with the hypoth-
esis that viral infection of the CNS occurs as a result of re-
cruitment of monocyte/macrophages from the periphery.
 
Confocal Microscopy Studies.
 
Although it has not been
demonstrated in vivo, it is possible that parenchymal mi-
croglia can upregulate CD14 as has been demonstrated in
vitro (53). For this reason, and to further investigate the cell
types infected in the CNS, we performed multilabel confo-
cal microscopy of normal CNS and CNS from SIV-
Figure 3. Perivascular macrophages are infected in the CNS of animals
at peak viremia. (A) SIV in situ hybridization–positive cells in the CNS in
a perivascular location. (B) CD14 immunoreactivity on a serial section
demonstrating that the in situ–positive cells shown in A are CD14-posi-
tive perivascular macrophages. (C) Double-label immunohistochemistry
for detection of CD14 (red) and viral protein (gp120; blue). Essentially all
of the cells in this perivascular cuff are CD141gp1201 (purple) perivascu-
lar macrophages. (D) Double-label immunohistochemistry on a tissue
section from the thymus of an SIV-infected animal demonstrating single-
color controls using a macrophage marker (red) and anti-SIV–gp120
(blue). Thymus tissues as single color controls were performed in parallel
with all double-label immunohistochemistry experiments. Results are
representative of immunohistochemical studies performed on two to
three CNS regions of n 5 5 animals killed at peak viremia.
Figure 4. Perivascular macrophages
are the major target of SIV in animals
with SIVE. Double-label immunohis-
tochemistry for CD14 (red) and viral
protein (gp120; blue). Colocalization
results in purple cells. (A) Numerous
CD141 perivascular macrophages
within an SIVE lesion. Few of the
CD141 cells (red) in this lesion are in-
fected as demonstrated by the small
number of purple cells. (B) Numerous
CD141 perivascular macrophages are
viral infected (purple) in a different le-
sion in the CNS of the same animal.
(C) A MNGC that is CD141 and gp1201 (purple) suggesting that MNGCs arise from the fusion of CD141 perivascular macrophages and not CD142
parenchymal microglia. Results are representative of immunohistochemical studies performed on two to three CNS regions of n 5 5 animals with SIVE.910 Perivascular Brain Macrophages in SIV Infection
infected animals with SIVE. Confocal microscopy for
CD11b and CD14 combined with Glut-1 for CNS endo-
thelium confirmed that these markers are differentially ex-
pressed on brain macrophage populations in vivo: CD11b
expression was found on parenchymal microglia and
perivascular macrophages whereas CD14 expression was
limited to perivascular macrophages (Fig. 5). CD11b ex-
pression on parenchymal microglia revealed a reticular net-
work of cells throughout the brain. Parenchymal microglia
in the brain of animals with SIVE have morphology consis-
tent with activated cells and express activation antigens in-
cluding HLA-DR, CD16, and CD69 (data not shown).
However, these activated parenchymal microglia maintain
their reticular network in the CNS white matter and do
not express detectable CD14 (Figs. 5 and 6). Thus, they
can be differentiated from perivascular macrophages (38,
39, 55–57). In agreement with the immunohistochemical
observations, the number of perivascular macrophages was
low in the normal CNS and increased in the CNS of ani-
mals with SIVE (Fig. 6). These confocal microscopy studies
also clearly show the intimate association of both parenchy-
mal microglia and perivascular macrophages with Glut-11
CNS endothelial cells (Fig. 5). Perivascular macrophages
wrap around the vessels while parenchymal microglia have
foot processes that contact vessels forming part of the
blood–brain barrier (15, 17).
To further examine the cell type infected, multilabel
confocal microscopy with anti-SIV p28, CD14, and Glut-1
was performed (Fig. 7). Similar to double-label immuno-
histochemistry and in situ hybridization followed by im-
munohistochemistry on serial sections, we found in all cases
that the SIV-p281 cells were CD141 perivascular mac-
rophages (Fig. 7). These data clearly demonstrate that
perivascular macrophages are productively infected in vivo.
A number of other reports suggest that other cell types can
be infected (14, 26, 58–61). However, most of these studies
have relied on anatomic location or morphology to identify
the infected cell types, making it difficult to differentiate
between trafficking mononuclear cells, CNS endothelium,
and processes of parenchymal microglia and astrocytes. For
this reason, we undertook additional multilabel confocal
microscopy studies to more rigorously identify perivascular
macrophages (CD11b1CD141), parenchymal microglia
(CD11b1CD142), astrocytes (GFAP1), and CNS endothe-
Table II. Percentage of CD14 and SIV-gp120 Single- and 
Double-positive Cells in the CNS of Animals with SIVE
Animal CD141gp1202 CD141gp1201 CD142gp1201
A97-6 63 36 0.6
A95-346 84 16 0.0
A95-383 76 24 0.0
Cell counts were acquired using brain sections from at least two different
brain regions, examining five sections per region, per animal. A minimum
of 300 cells were counted per brain region. MNGCs were counted as 1 cell.
CD141gp1202, noninfected perivascular macrophages; CD141gp1201,
infected perivascular macrophages; CD142gp1201, other cells (for example,
parenchymal microglia or CD41 T lymphocytes that are virally infected).
Figure 5. Triple-label confocal microscopy of the brain of an SIV-
infected macaque. Images for individual channels (CD11b, green; Glut-1,
red; and CD14, blue) are shown on the left and a larger merged image
contain all three channels plus the differential interference contrast (DIC)
image are shown on the right. Parenchymal microglia (CD11b, green)
maintain a reticular network in the white matter of SIV-infected
macaques. Perivascular macrophages (CD11b1CD141, blue-green) are
situated around CNS endothelium (Glut-1, red). Both parenchymal mi-
croglia (green) and perivascular macrophages (blue-green) are in contact
with CNS endothelium where parenchymal microglia have foot processes
on endothelium (arrows) and perivascular macrophages are in contact
with and wrap around CNS vessels. Bar, 10 mM.
Figure 6. Accumulation of perivascular macrophages in the CNS of
SIV-infected macaques. Images for individual channels (CD11b, green;
Glut-1, red; and CD14, blue) are shown on the left and the merged im-
age combining all three channels plus the DIC image are shown on the
right. CD11b1 (green) and CD141 (blue) perivascular macrophages
(blue-green) accumulate around a CNS vessel (Glut-1, red) in an SIVE
lesion. Parenchymal microglia that are CD11b1CD142 (green) outside of
the lesion area maintain a reticular network, although their morphology
has changed as a result of activation. Bar, 10 mM.911 Williams et al.
lium (Glut-11) to determine if cells other than perivascular
macrophages were infected in the CNS of animals with
SIVE (Figs. 7 and 8). In our extensive analysis of tissue sec-
tions from animals with SIVE, we did not detect Glut-11
endothelium, GFAP1 astrocytes, or CD11b1CD142 pa-
renchymal microglia that were also SIV-p281.
Analysis of SIV DNA, RNA, and Protein throughout Infec-
tion. There are numerous reports of SIV or HIV in the
CNS of macaques and humans that die with AIDS (27, 32,
46). In addition, several groups have reported SIV or HIV
in the CNS soon after infection (28–30, 43). However, it is
not clear whether virus in the CNS early after infection re-
sults in persistent productive infection or in productive in-
fection that is not sustained and requires repeated seeding of
the brain with virus from the periphery. To address this
question, groups of animals were infected with either the
molecular clone SIVmac239 or uncloned SIVmac251. Both
SIVmac239 and SIVmac251 are pathogenic viruses. Infec-
tion of macaques with SIVmac239 or SIVmac251 results in
similar viral loads and these viruses have similar chemokine
receptor usage. Both of these viruses cause AIDS and SIVE
in a similar time frame and percentage of animals (46).
Frontal cortex and brain stem were collected from animals
at 3, 7, 14, 21, and 50 d p.i., and from animals with AIDS
and SIVE and analyzed for viral DNA, RNA, and protein.
Nested PCR for viral DNA (gag) demonstrated that SIV
was detectable in the CNS as early as 7 d p.i. and consis-
tently by 14 d p.i. Once detected in the CNS, viral DNA
was detected at all later time points including animals with
terminal AIDS and SIVE (Table III). In contrast, studies on
the presence of viral RNA by in situ hybridization or viral
protein (SIV-gp120 or SIV-p28) by immunohistochemistry
revealed scattered positive cells associated with vessels 7–14 d
p.i., which were absent at later time points until terminal
AIDS. These data are similar to those in humans where
HIV-infected cells have been found in the CNS within
days after infection (43) and at terminal AIDS (6, 24–27),
but viral RNA- and protein-positive cells cannot be found
Figure 7. SIV-infected perivascular macrophages. Images for individual
channels (SIV-p28, green; Glut-1, red; and CD14, blue) are shown on
the left, and the merged image combining all three channels plus the DIC
image is shown on the right. Perivascular macrophages (CD14, blue) that
are viral protein positive (SIV-p28, green) appear blue-green near a CNS
vessel (Glut-1, red). Bar, 10 mM.
Figure 8. CNS macrophages are the target of SIV infection in animals
with SIVE. CNS macrophages (CD11b, green), astrocytes (GFAP, yel-
low), CNS endothelial cells (Glut-1, red), and viral protein (SIV-p28,
blue) were examined to assess whether cells other than macrophages were
productively infected. The image shows a combination of the four chan-
nels plus the DIC image. Extensive analysis of multiple brain regions from
n 5 5 animals with SIVE demonstrated p28-positive infected cells were
exclusively CD11b1 macrophages. Bar, 10 mM.
Table III. Assessment of Viral DNA, RNA, and Protein in the 
CNS As a Function of Time After Infection
Day
3
Day
7
Day
14
Day
21
Day
50 SIVE
SIV DNA 
SIVmac239 21 /21 1 1 1
SIVmac251 21 /21 1 1 1
SIV RNA
SIVmac239 21 /21 /22 2 1
SIVmac251 21 /21 /22 2 1
SIV protein
SIVmac239 21 /21 /22 2 1
SIVmac251 21 /21 /22 2 1
Data presented here are the results of n 5 2 animals per data point per
viral inoculum. Viral DNA was assessed using PCR for gag. Viral RNA
was assessed using in situ hybridization with SIV-specific riboprobes.
Viral protein was assessed by immunohistochemistry for SIV-gp120 and
SIV-p28. 2, not detected; 1/2, detected in scattered cells or samples;
1, detected in all tissues or samples examined.912 Perivascular Brain Macrophages in SIV Infection
in the CNS of HIV-infected, asymptomatic patients (62,
63). In our study and in studies of HIV-infected, asymp-
tomatic humans, although viral RNA and protein were not
detected, viral DNA was. This DNA might be from latently
infected cells or from contaminating cells that were trapped
in the CNS vasculature at the time of death (62, 63).
In terminal animals with AIDS and SIVE, there were
numerous cells with abundant viral RNA and protein (Ta-
ble III). These results are similar to previous observations
in macaques and humans (5, 26, 27, 29, 30). These data
confirm that SIV neuroinvasion occurs very rapidly but
suggests that the initial productive infection of the brain
parenchyma is not maintained or occurs at a very low level
after 14 d of infection until terminal AIDS. The preferen-
tial infection of perivascular macrophages and not paren-
chymal microglia may account for the early productive vi-
ral infection, disappearance, and reappearance of SIV in
the CNS.
Discussion
In this study we immunophenotypically differentiate
subpopulations of brain macrophages into perivascular
macrophages and parenchymal microglia and demonstrate
that perivascular macrophages are the major cell produc-
tively infected by SIV in the CNS of macaques. Preferen-
tial infection of perivascular macrophages in the CNS may
account for several important observations concerning in-
fection of the CNS, viral dynamics in the CNS, and the
role of the CNS as a viral sanctuary or reservoir.
Although it has not been directly demonstrated, it is
generally assumed that lentiviruses enter the CNS by the
traffic of infected monocyte/macrophages (64). Our data
showing that perivascular macrophages are the major cell
type, infected in the brain, support this hypothesis. Studies
in chimeric rodents and humans receiving bone marrow
indicate that perivascular macrophages are continuously re-
placed from the circulation (15–17, 43). The immu-
nophenotype described for perivascular macrophages,
CD11b1CD141CD451, is consistent with circulating pe-
ripheral blood monocytes, some of which may be destined
to traffic to the CNS (38, 39, 41, 42, 53, 65). Whether in-
fected or not, our data suggest that it is this population that
comprises the majority of the lesions in the CNS of animals
with SIVE. Cells of this immunophenotype have been pre-
viously noted in the blood of HIV-infected individuals
where their percentages are increased in response to infec-
tion (66–68). Pulliam and Gartner have described a popula-
tion of circulating blood monocytes that express CD14,
CD16, and CD69 which may be HIV infected and whose
presence appears to correlate with the development of
ADC (69, 70). The perivascular macrophages that accumu-
late in the CNS- of SIV-infected macaques have essentially
the same immunophenotype.
Our data on viral DNA, RNA, and protein supports the
observations by others that virus enters the CNS early in
infection (28–30, 43). Our data further suggests that pro-
ductive infection of the CNS occurs for a limited amount
of time or at very low levels beyond 2 wk p.i. until termi-
nal AIDS. Similar observations where viral DNA can be
found in the absence of viral RNA or protein have been
made in the CNS of HIV-infected humans who died from
non-AIDS causes during the asymptomatic period (62, 63).
Recent reports have noted similar observations in human
(44) and monkey (45) cerebral spinal fluid where there is
early detection of virus in these compartments that sub-
sides, then reappears with the progression to AIDS. The
demonstrated kinetics of perivascular macrophage turnover
in the CNS may in part account for appearance of virus
early in the CNS after infection and then disappearance of
virus until terminal AIDS. Perivascular macrophages in ro-
dents and humans are repopulated at a constant rate that is
accelerated in inflammatory conditions such as viral infec-
tion or autoimmune reactions (15, 16, 71). The early pres-
ence of virus in the CNS appears to occur by the traffic of
monocytes that are potentially programmed to become
perivascular macrophages in the CNS. Furthermore, the
traffic of these cells, as demonstrated by the presence of vi-
ral DNA, RNA, and protein in the CNS, coincides with
peak viremia (28, 29). Once viremia subsides in the clini-
cally latent period, it is possible that the monocytes that
continue to traffic to the CNS are no longer infected or
that the number of infected cells is greatly diminished by
the host immune response, making it difficult to detect ac-
tive viral replication. Later in disease, when individuals de-
velop AIDS and the immune system has failed, once again
the number of infected monocytes that traffic to the CNS
may be increased. It has been demonstrated that perivascu-
lar macrophages can leave the CNS (72). Whether virally
infected perivascular macrophages also can leave the CNS
is unknown. The mechanism for retention and accumula-
tion of infected and noninfected perivascular macrophages
at terminal AIDS is undefined, but appears to correlate
with dysfunction of the cellular immune system.
Numerous reports indicate that HIV and SIV infect
brain macrophages/microglia; however, these studies have
not distinguished between perivascular macrophages and
parenchymal microglia (5, 7, 8, 10, 14, 25–31, 58, 73). Other
cell types that have been reported to be infected include as-
trocytes and endothelial cells (26, 58–61). Our double-label
immunohistochemistry and multilabel confocal microscopy
data failed to demonstrate productive infection of paren-
chymal microglia, astrocytes, or endothelial cells in vivo.
One difficulty in interpretation of earlier reports of the in-
fection of astrocytes, endothelium, and microglia in adults
is the extensive use of cell lines or primary cultures for
these infection studies. Another difficulty is the lack of
double labels for the identification of the infected cell type,
and the use of imaging techniques which do not allow for
sufficient resolution to differentiate two closely opposed
cells (e.g., endothelium and perivascular macrophages). At
the light microscopic level, it is difficult to distinguish be-
tween endothelial cells, perivascular macrophages, or leu-
kocytes migrating into the brain (26, 59). With regard to
macrophage subpopulations and distinguishing between913 Williams et al.
perivascular macrophages and parenchymal microglia, few
double-label immunohistochemistry studies have been per-
formed. The double-label studies that have been done to
date on CNS macrophage populations have used CD68 or
Ricinus comminis agglutinin 1 (RCA-1) that identify all
brain macrophages, including perivascular macrophages
and microglia (5, 28).
Most in vitro studies of brain macrophage infection as it
might relate to the neuropathogenesis of AIDS have relied
on parenchymal microglia (5, 7, 8, 10, 11, 14). However, it
is known that in vitro parenchymal microglia become
highly activated within hours and are quite different from
their in vivo or immediately ex vivo counterparts (41, 53).
Although supernatant from infected microglia can cause
neuronal injury and death (7, 8, 10, 11, 74, 75), it is diffi-
cult to appreciate the significance of such observations in
light of the difference between the biology of perivascular
macrophages and parenchymal microglia.
Our studies demonstrate that perivascular macrophages
are immunophenotypically distinct from the resident pa-
renchymal microglia. We further demonstrate that perivas-
cular macrophages are the major cell type productively in-
fected in the CNS of macaques at peak viremia and with
SIVE. Within SIVE lesions, noninfected perivascular mac-
rophages are the major cell population followed by infected
perivascular macrophages. These data potentially point to
cells in the blood that may function as a trojan horse carry-
ing virus to the CNS. Our data suggest that the accumula-
tion of perivascular macrophages, which is coincident with
CNS pathology and development of ADC, occur late in
infection, with the development of terminal AIDS.
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